Article Details

Leap Therapeutics (NASDAQ:LPTX) Downgraded by Zacks Investment Research to "Hold"

Retrieved on: 2021-01-07 05:37:30

Tags for this article:

Click the tags to see associated articles and topics

Leap Therapeutics (NASDAQ:LPTX) Downgraded by Zacks Investment Research to "Hold". View article details on hiswai:

Excerpt

BlackRock Inc. now owns 105,674 shares of the company's stock valued at $209,000 after buying an additional 36,833 shares in the last quarter. 47.31 ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo